MacDougall Biomedical Communications Home    Sitemap    Contact Us

  
   
 

Building Visibility & Valuation for the Life Sciences Industry

MacDougall Biomedical Communications brings a fresh, strategic approach to building visibility and valuation for its clients within the biotechnology, medical device, and life science industries.

Learn more >>

  
     
 

Amplify Your Success Around the Globe

MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.

Learn more >>

  
     
 

Build Credibility and Liquidity on Wall St.

MBI has a seasoned investor relations team that has helped over 22 companies go public and a proven track record of building or restoring credibility with investors and analysts.

Learn more >>

  
     
 

Branding and Positioning are the Keys to Long-term Success

MacDougall Biomedical Communications specializes in branding and rebranding private and public life science companies. A clear and consistent corporate message is the keystone to a successful communications plan.

Learn more >>

  
     
 

Get Your Message to the Right Audience at the Right Time

MBI monitors and evaluates important industry events to proactively secure opportunities for its clients.

Learn more >>

  
     
 

Building Visibility & Valuation for the Life Sciences Industry

MacDougall Biomedical Communications brings a fresh, strategic approach to building visibility and valuation for its clients within the biotechnology, medical device, and life science industries.

Learn more >>

  
     
 

Amplify Your Success Around the Globe

MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.

Learn more >>

  
     
 

Build Credibility and Liquidity on Wall St.

MBI has a seasoned investor relations team and a proven track record of building or restoring credibility with investors and analysts.

Learn more >>

  
     
 

Branding and Positioning are the Keys to Long-term Success

MacDougall Biomedical Communications specializes in branding and rebranding private and public life science companies. A clear and consistent corporate message is the keystone to a successful communications plan.

Learn more >>

  
     
 

Get Your Message to the Right Audience at the Right Time

MBI monitors and evaluates important industry events to proactively secure opportunities for its clients.

Learn more >>

  
     
   

MBI is a leading strategic communications firm focused on scientific, medical and corporate communications. MacDougall Biomedical Communications' sole focus is to fulfill the unique communications needs of companies and organizations that are developing products or services within the life sciences industry. Our client profiles include:
  • Private and public biotechnology companies
  • Global and specialty pharmaceutical companies
  • Medical device and diagnostic companies
  • Universities and research institutions
  • National and international biotechnology industry organizations
  • International economic development organizations
  • Organizations providing support services/products for the life sciences industry

The team at MBI prides itself on being innovative and creative with a direct, honest and results-oriented approach.

  

Download 2009 Life Science Industry Conference Calendar


Industry Resources

more >

  
           
 
[ about us | services | clients | creative studio ]
 © 2009 MacDougall Biomedical Communications  |  Privacy Policy  
Achillion Pharmaceutics (ACHN) Array BioPharma (ARRY) CellDex (CLDX) Clinical Data (CLDA) CombinatoRx (CRXX) Dyax Corporation (DYAX) Idera Pharmaceuticals (IDRA) Microfluidics Corporations (MFLU) Myriad Pharmaceuticals (MYRX) NovaDel Pharma Inc. (NVD) Pro-Pharmaceuticals, Inc. (PRWP) SeraCare Life Sciences (SRLS) Synta Pharmaceuticals (SNTA) Targacept (TRGT) Vertex (VRTX) ZymoGenetics, Inc. (ZGEN) Acetylon Pharmaceuticals Advanced Molecular Design Advanced Molecular Design Aileron Therapeutics Arcion Therapeutics Argos Therapeutics Artisan Pharmaceuticals Ascent Pharmaceuticals BioAssets Development Corp Boston Biocom CaliberTherapeutics Cambria Biosciences CircuLite, Inc. Conatus Pharmaceuticals CORTRIA Corporation Dimerix Enanta Pharmaceuticals Enlight Biosciences Epitome Biosystems Extera Partners FORMA Therapeutics Fate Therapeutics Gloucester Pharmaceuticals Good Start Genetics HistoRx Inotek Pharmaceuticals Kem Pharmaceuticals Mersana Nativis NeurAxon Neurotech USA Nomir Medical NovaDigm Therapeutics PICO Pharmaceuticals Proteostasis Therapeutics ROXRO Pharmaceuticals Saladax Biomedical SCYNEXIS, Inc. Seaside Therapeutics SmartCells, Inc. SRU Biosystems Surface Logix Symphogen Synageva BioPharma Taligen Therapeutics Tetraphase Pharmaceuticals Topigen Pharmaceuticals VirDante Pharmaceuticals Zelos Therapeutics AstraZeneca Biotechnology Industry Organization Excel Ventures Management Galderma Halloran Harvard Clinical Research Institute HealthCap PureTech Ventures Red Sky Partners